Department of Translational Oncology
Biomarker and Therapeutic Target Research Core,
Fundamental Innovative Oncology Core Center (FIOC),
National Cancer Center
The three major research areas of the Department of Translational Oncology were 1) preclinical studies using newly established gastric, esophageal, pancreatic, and ovarian cancer cell lines for derivation of industrial and academia seeds/drugs to the Exploratory Oncology Research & Clinical Trial Center (EPOC), 2) basic research and development of personalized cancer diagnosis and treatment for gastric cancer (GC) and esophageal squamous cell carcinoma (ESCC), and 3) we supported microarray analysis and gene selection for inside and outside researchers as a work of the core facility in the Fundamental Innovative Oncology Core Center (FIOC).